Signal transduction in hepatic stellate cells

Liver

Volumn 18, Issue 1, 1998, Pages 2-13

  Pinzani, Massimo ^a   Marra, Fabio ^a   Carloni, Vinicio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Endothelin; Fibrogenesis; Integrins; MAP kinases; Platelet derived growth factor; Signal transduction; Stellate cells

Indexed keywords

CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE; GROWTH FACTOR; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RECEPTOR; VASOACTIVE AGENT;

CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INFILTRATION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CELL SECRETION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; ITO CELL; LEUKOCYTE; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; NEUTROPHIL CHEMOTAXIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 0031930768     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00120.x     Document Type: Review

References (86)

1. FRIEDMAN S L. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-35.
2. PINZANI M. Novel insight into the biology and physiology of the Ito cell. Pharmac Ther 1995; 66: 387-412.
3. LALAZAR A, WONG L, YAMASAKI G, FRIEDMAN S L. Early genes induced in hepatic stellate cells during wound healing. Gene 1997; 195: 235-43.
4. RATZIU V, KIM S J, KIM Y S, et al. A key role for ZF9 in hepatic fibrosis via its transcriptional activation of TGFβ1 and types I and II TGFβ receptor genes in rat stellate cells. Hepatology 1997; 26: 185A (abstract).
5. LEE K S, BUCK M, HOUGLUM K, CHOJKIER M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96: 2461-68.
6. LEE K S, COTTAM H B, HOUGLUM K, et al. Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitor activity. Am J Physiol 1997; 273: G1094-G1100.
7. HOUGLUM K, LEE K S, CHOJKIER M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J Clin Invest 1997; 99: 1322-8.
8. REEVES H L, PEAK M, BURT A D, DAY C P. The role of stress-activated protein kinases in the activation of hepatic stellate cells. Hepatology 1997; 26: 448A (abstract).
9. COHEN P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 1997; 7: 353-61.
10. SAILE B, KNITTEL T, MATTHES N, et al. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol 1997; 151: 1265-72.
11. PINZANI M, GESUALDO L, SABBAH G M, ABBOUD H E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84: 1786-93.
12. PINZANI M, ABBOUD H E, GESUALDO L, ABBOUD S L. Regulation of macrophage-colony stimulating factor in liver fat-storing cells by peptide growth factors. Am J Physiol Cell Physiol 1992; 262: C876-C881.
13. PINZANI M, GENTILINI A, CALIGIURI A, et al. Transforming growth factor-β1 regulates platelet-derived growth factor β subunit in human liver fat-storing cells. Hepatology 1995; 21: 232-39.
14. PINZANI M, MILANI S, GRAPPONE C, et al. Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology 1994; 19: 701-7.
15. PINZANI M, MILANI S, HERBST H, et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996; 148: 785-800.
16. CLAESSON-WELSH L. Platelet-derived receptor signals. J Biol Chem 1994; 269: 32023-6.
17. COHEN G B, REN R, BALTIMORE D. Modular binding domain in signal transduction proteins. Cell 1995; 80: 237-48.
18. PAWSON T. Protein modules and signalling networks. Nature 1995; 373: 573-80.
19. MARSHALL C J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.
20. MARSHALL C J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 1994; 4: 82-9.
21. MAPK are required for fibroblast proliferation. Proc Natl Acad Sci USA 1993; 90: 8319-23.
22. MARRA F, PINZANI M, DEFRANCO R, et al. Involvement of phoshatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. FEBS Lett 1995; 376: 141-5.
23. MARRA F, GHOSH CHOUDHURY G, ABBOUD HE. Interferon-γ-mediated activation of STAT1α regulates growth factor-induced mitogenesis. J Clin Invest 1996; 98: 1218-30.
24. PINZANI M, MARRA F, CALIGIURI A, et al. Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells. Br J Pharmacol 1996; 119: 1117-24.
25. WU J, DENT P, JELINEK T, et al. Inhibition of the EGF-activated MAP kinase signalling pathway by adenosine 3′,5′-monophosphate. Science 1993; 262: 1065-9.
26. GRAVES L M, BORNFELT K E, RAINES E W, et al. Protein kinase A antagonizes platelet-derived growth factor-induced signalling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA 1993; 90: 10300-4.
27. PARKER P J, WATERFIELD M D. Phosphatidylinositol 3-kinase: a novel effector. Cell Growth Differ 1992; 3: 747-52.
28. VALIUS M, KAZLAUKAS A. Phospholipase C-gamma and phosphatidylinositol 3-kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 1993; 73: 321-34.
29. KUNDRA V, ESCOBEDO J A, KAZLAUKAS A, et al. Regulation of chemotaxis by platelet-derived growth factor receptor beta. Nature 1993; 367: 474-6.
30. MARRA F, GENTILINI A, PINZANI M, et al. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology 1997; 112: 1297-306.
31. BORNFELT K E, RAINES E W, NAKANO T, et al. Insulin-like growth factor I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are disctinct from those of proliferation. J Clin Invest 1994; 93: 1266-74.
32. DARNELL JR J E. STATs and gene regulation. Science 1997; 277: 1630-3.
33. ROCKEY D C, MAHER J J, JARNAGIN W R, et al. Inhibition of rat hepatic lipocytes activation in culture by interferon-γ. Hepatology 1992; 16: 776-84.
34. KAWADA N, UOYA M, SEKI S, et al. Regulation by cAMP of STAT1 activation in hepatic stellate cells. Biochem Biophys Res Commun 1997; 233: 464-9.
35. PINZANI M, KNAUSS T C, PIERCE G F, et al. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am J Physiol 1991; 260: C485-C491.
36. KONDO T, KONISHI F, INUI H, INAGAMI T. Differing signal transduction elicited by three isoforms of platelet-derived growth factor in vascular smooth muscle cells. J Biol Chem 1993; 268: 4458-64.
37. 2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts. Am J Physiol 1993; 265: C1239-C1246.
38. FAILLI P, RUOCCO C, DEFRANCO R, et al. The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx. Am J Physiol 1995; 269: C1133-C1139.
39. DI SARIO A, SVEGLIATI BARONI G, BENDIA E, et al. Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. Am J Physiol 1997; 273: G39-G48.
40. + exchange activation in hepatic stellate cells. Hepatology 1997; 26: 130A (abstract).
41. ROCKEY D C. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin and nitric oxide. Hepatology 1997; 25: 2-5.
42. PINZANI M. Increased vascular tone in cirrhotic liver: the role of stellate cells. In: Arroyo V, Bosch J, Bruguera M, Rodès J eds. Therapy in liver diseases. The pathophysiological basis of therapy. Barcelona: Masson S.A., 1997: 35-41.
43. PINZANI M, FAILLI P, RUOCCO C, et al. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 1992; 90: 642-6.
44. BATALLER R, NICOLAS J M, GINÈS P, et al. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. Gastroenterology 1997; 113: 615-24.
45. 125I-endothelin-1 to fat-storing cells in rat liver revealed by electron microscopic radioautography. Anat Embryol 1992; 185: 97-100.
46. GONDO K, UENO T, MASAHARU S, et al. The endothelin-1 binding site in rat liver tissue: light- and electron- microscopic autoradiographic studies. Gastroenterology 1993; 104: 1745-9.
47. HOUSSET C N, ROCKEY D C, BISSEL D M. Endotelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA 1993; 90: 9266-70
48. PINZANI M, MILANI S, DEFRANCO R, et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996; 110: 534-48.
49. WANG Y Z, POUYSSEGUR J, DUNN M J. Endothelin stimulates mitogen-activated protein-kinase activity in mesangial cells through ET(A). J Am Soc Nephrol 1994; 5: 1074-80.
50. MALLAT A., FOUASSIER F, PREAUX AM, et al. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells: an endothelin B receptor-mediated pathway. J Clin Invest 1995; 96: 42-9.
51. MALLAT A, PREAUX A-M, SERRADEIL-LE GAL C, et al. Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. J Clin Invest 1996; 98; 2771-8.
52. HYNES R O. Integrins: versatility, modulation and signalling in cell adhesion. Cell 1992; 69: 11-25.
53. CARLONI V, ROMANELLI R G, PINZANI M, et al. Expression and function of integrins receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology 1996; 110: 1127-36.
54. HALL D E, REICHARDT L F, CROWLEY E, et al. The α1β1 and α6β1 integrin heterodimers mediate cell attachment to distinct sites on laminin. J Cell Biol 1990; 110: 2175-84.
55. GULLBERG D, GEHLSEN K R, TURNER D C, et al. Analysis of α1β1, α2β1, and α3β1 integrins in cell-collagen interactions: identification of conformation dependent α1β1 binding sites in collagen type I. EMBO J 1992; 11: 3865-73.
56. BURRIDGE K, TURNER C E, ROMER L H. Tyrosine phosphorylation of paxillin and pp125 FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 1992; 119: 893-903.
57. SCHALLER M D, PARSONS J T. Focal adhesion kinase: an integrin-linked protein tyrosine kinase. Trends Cell Biol 1993; 3: 258-62.
58. SCHALLER M D, OTEY C A, HILDEBRAND J D, PARSONS J T. Focal adhesion kinase and paxillin bind to peptides mimicking β integrin cytoplasmic domains. J Cell Biol 1995; 130, 1181-7.
59. CHEN H-C, GUAN J-L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1994; 91: 10148-52.
60. RANKIN S, ROZENGURT E. Platelet-derived growth factor modulation of focal adhesion kinase (pp125 FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. J Biol Chem 1994; 269: 704-10.
61. MCNAMEE H M, INGBER D E, SCHWARTZ M A. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J Biol Cell 1993; 121: 673-8.
62. CARLONI V, ROMANELLI R G, PINZANI M, et al. Focal adhesion kinase and phospholipase Cγ involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 1997; 112: 522-31.
63. SCHAEPFER D D, HANKS S K, HUNTER T, VAN DER GEER P. Integrin-mediated signal transduction linked to Ras pathway by Grb2 binding to focal adhesion kinase. Nature 1994; 372: 786-91.
64. RENSHAW M W, REN X D, SCHWARTZ M A. Growth factor activation of MAP kinase requires cell adhesion. EMBO J 1997; 16: 5592-9.
65. HOUGLUM K, BUCK M, ALCORN J, et al. Two different cis-acting regulatory regions direct cell-specific transcription of the collagen α1 (I) gene in hepatic stellate cells and in skin and tendon fibroblasts. J Clin Invest 1995; 96: 2269-76.
66. STEFANOVIC B, HELLERBRAND C, HOLCIK M, et al. Post transcriptional regulation of collagen α1 (I) mRNA in hepatic stellate cells. Mol Cell Biol 1997; 17: 5201-9.
67. MASSAGUE J, HATA A, LIU F. TGF-β signalling through the Smad pathway. Trends Cell Biol 1997; 7: 187-92.
68. ROULOT D, BISSELL D M. The TGFβ type II receptor may mediate the anti-proliferative, but not the profibrogenic, effect of TGFβ: studies in human and experimental liver injury. Hepatology 1997; 26: 371A (abstract).
69. REINMANN T, HEMPEL U, KRAUTWALD S, et al. Transforming growth factor-β1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett 1997; 403: 57-60.
70. DAVIS B H, CHEN A, BENO D W A. Raf and mitogen-activated protein kinase regulate stellate cell collagen gene expression. J Biol Chem 1996; 271: 11039-42.
71. ARMENDARIZ-BORUNDA J, SIMKEVICH C P, ROY N, et al. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J 1994; 304: 817-24.
72. CHEN A, BENO D W A, DAVIS B H. Suppression of stellate cells type I collagen gene expression involves AP-2 transmodulation of nuclear factor-1-dependent gene transcription. J Biol Chem 1996; 271: 25994-8.
73. HERNANDEZ-MUNOZ I, DE LA TORRE P, SANCHEZ-ALCAZAR J A, et al. Tumor necrosis factor α inhibits collagen α1 (I) gene expression in rat hepatic stellate cells through a G protein. Gastroenterology 1997; 113: 625-40.
74. MOSHAGE H, CASINI A, LIEBER C S. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 1990; 12: 511-8.
75. CASINI A, CUNNINGHAM M, ROJKIND M, LIEBER CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991; 13: 758-65.
76. CASINI A, GALLI G, SALZANO R, et al. Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation. Alcohol Alcohol 1994; 29: 303-14.
77. PAROLA M, PINZANI M, CASINI A, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen α1 (I) gene expression in human liver fat-storing cell. Biochem Biophys Res Commun 1993; 194: 1044-50.
78. PAROLA M, PINZANI M, CASINI A, et al. Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. Biochem Biophys Res Commun 1996; 221: 261-4.
79. ROBINO G, PAROLA M, MARRA F, et al. JNK activation by 4-hydroxynonenal in human hepatic stellate cells: a non oxidant and non proliferative link between oxidative stress and nuclear signaling. Hepatology 1997; 16: 372A (abstract).
80. REEVES H L, PEAK M, BURT A D, DAY C P. Interferon α inhibits p38 MAP kinase activity in hepatic stellate cells. Hepatology 1997; 16: 447A (abstract).
81. PINZANI M, ABBOUD HE, GESUALDO L, ABBOUD SL. Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. Am J Physiol 1992; 262: C876-C881.
82. PINZANI M, CARLONI V, MARRA F, et al. Biosynthesis of platelet-derived growth factor and its 1O-acyl analogue by liver fat-storing cells. Gastroenterology 1994; 106: 1301-11.
83. MARRA F, VALENTE A J, PINZANI M, ABBOUD H E. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest. 1993; 92: 1674-80.
84. MARRA F, DEFRANCO R, GRAPPONE C, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 1998; in press.
85. MAPK is required for cytokine-stimulated expression of monocyte chemotactic protein-1 in stellate cells. Hepatology 1997; 26: 184A (abstract).
86. TSUKAMOTO H, WANG S C, LIN M, et al. NF-kB activation and chemokine expression by hepatic stellate cells in cholestatic liver injury. Hepatology 1996; 24: 331A (abstract).